Vaccine Acceptors, Refusers, and the Moveable Middle (October 2022 Study Published)
In October 2022 the Litaker Group published a peer-reviewed study in Vaccines assessing qualitative factors of individuals who are vaccine
Read moreNews and Updates
COVID-19 Vaccine Hesitancy in Austin – 2022 Study Published
A first of its kind study in Central Texas, researchers from The Litaker Group and Sendero Health Plans identify sociodemographic
Read more1.7 Million Doses of the COVID-19 Vaccine Needed in Austin To Reach Herd Immunity (January 2021)
The Litaker Group team of researchers published a manuscript in Frontiers in Public Health quantifying the number of COVID-19 doses
Read moreRCT to Assess Uptake of Medical Eye Exams Among Individuals with Diabetes Published in Ophthalmic Epidemiology (April 2020)
Diabetic retinopathy is a leading cause of blindness worldwide. In the United States, the prevalence of diabetic retinopathy is 26%
Read moreMedical Geography and Disease Detection – the SARS Example
In 2003 Dr. John Litaker and colleagues reviewed the SARS epidemic by focusing on geographical diffusion using central place theory
Read moreDr. John Litaker presents at the Northern Ontario School of Medicine (January 2020)
Dr. John Litaker presented at the Medical Science Division seminar series at the Northern Ontario School of Medicine on January
Read moreOpioid ED Visits Research in BMC Public Health (September 2019)
A study by John Litaker, PhD et al, published in BMC Public Health in September 2019, demonstrated the value of using health
Read moreDr. John R. Litaker at Buckingham Palace
Dr. John R. Litaker, managing director of the Litaker Group and president emeritus of the American Friends of the London
Read more